Transient Ischemic Attack

Clinical Trial Finder

Many patients who experience transient ischemic attacks (TIAs) are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Vulnerable Plaque Imaging in NSTEMI

Conditions:   Myocardial Infarction;   Myocardial Ischemia
Sponsor:   Maastricht University Medical Center
Not yet recruiting - verified September 2015

Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation

Conditions:   Transient Ischemic Attack;   Stroke;   Atrial Fibrillation
Interventions:   Drug: Apixaban;   Drug: Warfarin
Sponsors:   University of South Florida;   Bristol-Myers Squibb
Recruiting - verified September 2015

A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device

Condition:   Transient Ischemic Attack
Interventions:   Device: Transcranial Magnetic Stimulation;   Behavioral: Behavioral Assessments;   Other: Magnetic Resonance Imaging;   Other: EEG
Sponsor:   University of Wisconsin, Madison
Recruiting - verified October 2015

Colchicine For Prevention of Perioperative Atrial Fibrillation in Patients Undergoing Thoracic Surgery Pilot Study

Conditions:   Atrial Fibrillation;   Thoracic Surgery
Interventions:   Drug: Colchicine;   Drug: Colchicine Placebo
Sponsors:   McMaster University;   Canadian Institutes of Health Research  (CIHR)
Completed - verified October 2015

ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial

Condition:   Peripheral Endovascular Interventions
Intervention:   Drug: Bivalirudin
Sponsor:   The Medicines Company
Active, not recruiting - verified July 2014

Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients

Conditions:   Coronary Artery Disease;   Cerebral Vascular Disease;   Peripheral Artery Disease;   Renal Insufficiency;   Diabetes;   COPD;   Hypertension;   Active Smoker;   Cancer;   CHF;   Prior DVT/PE
Sponsor:   New York University School of Medicine
Withdrawn - verified October 2015

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

Conditions:   Stroke;   Atrial Fibrillation
Sponsor:   Boehringer Ingelheim
Recruiting - verified October 2015

Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement

Condition:   Severe Aortic Stenosis
Intervention:   Device: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Sponsor:   Medtronic Cardiovascular
Active, not recruiting - verified October 2015

GLORIA-AF Registry Program - Second and Third Phases

Conditions:   Stroke;   Atrial Fibrillation
Sponsor:   Boehringer Ingelheim
Recruiting - verified October 2015

Get CardioSmart

You're Invited